substance p has been researched along with Anemia, Sickle Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ericson, ME; Gupta, K; Gupta, M; Luk, K; Nguyen, J; Simone, DA; Vang, D; Vincent, L | 1 |
| Douglas, SD | 2 |
| Brandow, AM; Dasgupta, M; Hillery, CA; Hoffmann, RG; Panepinto, JA; Stucky, CL; Wandersee, NJ | 1 |
| Ericson, ME; Gupta, K; Gupta, P; Gupta, V; Hebbel, RP; Kehl, LJ; Khasabov, SG; Kohli, DR; Li, Y; Nguyen, J; Simone, DA | 1 |
| Pepple, DJ | 1 |
| Douglas, SD; Michaels, LA; Ohene-Frempong, K; Zhao, H | 1 |
7 other study(ies) available for substance p and Anemia, Sickle Cell
| Article | Year |
|---|---|
Mast cell activation contributes to sickle cell pathobiology and pain in mice.
Topics: Anemia, Sickle Cell; Animals; Benzamides; Cells, Cultured; Cytokines; Ganglia, Spinal; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hyperalgesia; Hypoxia; Imatinib Mesylate; Leukocyte Count; Mast Cells; Mice; Mice, Knockout; Mice, Transgenic; Microscopy, Confocal; Neurogenic Inflammation; Nociceptors; Pain; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Skin; Substance P | 2013 |
Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches.
Topics: Anemia, Sickle Cell; Biomarkers; Humans; Morpholines; Pain; Substance P | 2016 |
Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Biomarkers; Black or African American; Case-Control Studies; Child; Female; Hemolysis; Humans; Hydroxyurea; Male; Risk Factors; Substance P; Young Adult | 2016 |
Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.
Topics: Anemia, Sickle Cell; Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Agonists; Cannabinoids; Cyclohexanols; Disease Models, Animal; Female; Hemoglobin, Sickle; Humans; Hyperalgesia; Male; Mice; Mice, Knockout; Mice, Transgenic; Morphine; Neuroglia; Pain; Receptors, Opioid, mu; Recombinant Proteins; Skin; Spinal Cord; Substance P | 2010 |
The role of hypoxia and substance P in the painful crisis of homozygous sickle cell disease.
Topics: Anemia, Sickle Cell; Hematocrit; Homozygote; Humans; Hypoxia; Models, Biological; Models, Theoretical; Oxygen; Pain; Substance P | 2008 |
Elevated plasma substance P in sickle cell disease and vaso-occlusive crisis.
Topics: Anemia, Sickle Cell; Antiemetics; Aprepitant; Clinical Trials, Phase I as Topic; Humans; Models, Immunological; Morpholines; Neurokinin-1 Receptor Antagonists; Pain; Substance P | 2008 |
Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis.
Topics: Acute Disease; Adolescent; Anemia, Sickle Cell; Child; Child, Preschool; Female; Humans; Interleukin-8; Ischemia; Male; Pain; Substance P; Tumor Necrosis Factor-alpha | 1998 |